Artificial insemination is an assisted reproductive technology that involves inserting sperm directly into a woman's uterus or fallopian tubes.
Artificial insemination is an assisted reproductive technology that involves inserting sperm directly into a woman's uterus or fallopian tubes. It is often used to overcome fertility issues in women and is an accessible and affordable treatment option. The global artificial insemination market involves manufacturing of medical devices, media, and consumables required for intrauterine insemination or intracervical insemination procedures.
The global Artificial Insemination Market is estimated to be valued at US$ 9.2 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rising Prevalence of Infertility: The rising prevalence of infertility around the world due to factors such as increasing stress levels, obesity, sexually transmitted infections, and other health issues is a key driver of the artificial insemination market growth. According to the World Health Organization, infertility affects nearly 15% of couples worldwide. Several lifestyle changes along with delayed childbearing age have contributed to infertility rates. As artificial insemination is one of the widely adopted first-line treatment options, its demand has increased rapidly over the past few years.
Segment Analysis
The global Artificial Insemination market is dominated by the intrauterine insemination (IUI) sub-segment. IUI is one of the most common and cost-effective forms of assisted reproductive technology (ART) available today. It involves directly injecting washed and prepared sperm into the womb near the time of ovulation. IUI has a lower cost compared to other advanced fertility treatments and has an improved success rate compared to intercourse alone.
Key Takeaways
The global Artificial Insemination Market is estimated to be valued at US$ 9.2 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2030.
Regional analysis
The North American region presently leads the global Artificial Insemination Market and is anticipated to hold its dominance during the forecast period. This can be attributed to the rising public awareness about fertility preservation in countries like the US and Canada. In addition, the easy availability of advanced fertility treatments and the presence of major players in the region are also fueling the market growth. However, the Asia Pacific region is projected to witness the highest growth during the forecast period owing to the improving healthcare infrastructure, rising medical tourism, and surge in disposable incomes in developing countries like India and China.
Key players
Key players operating in the Artificial Insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. These players are focusing on expanding their footprint by entering into strategic partnerships with hospitals and fertility clinics to increase sales. Companies are also investing in research and development activities to develop advanced solutions.
Get More Insights On This Topic: https://www.newsanalyticspro.com/the-growing-synthetic-biological-market-offers-enormous-potential-for-fertility-advancement/
https://shoutingstars.com/pd-1-and-pd-l1-inhibitors-a-promising-cancer-immunotherapy
Comments
0 comment